Science-Backed Solutions for Lasting Weight Loss

Semaglutide and Tirzepatide are medications for adults designed to manage overweight and obesity. They are designed to help them lose weight and keep it off when used alongside a reduced-calorie diet and increased physical activity.

Semaglutide and Tirzepatide work by replicating a hormone in your body that regulates appetite and food intake. This can help you feel fuller sooner, thus reducing your portion sizes and overall calorie intake.

Yes, Semaglutide and Tirzepatide are designed to aid in weight loss by suppressing your appetite and helping you feel fuller. This is most effective when combined with a healthy diet and regular exercise.

Yes. Semaglutide and Tirzepatide can be used as part of a long-term weight-management plan. However, long-term use should be under the direction and supervision of a health care provider.

Remember to always consult with your channelside healthcare practitioner for personalized medical advice.

While most people tolerate Semaglutide and Tirzepatide well, some common side effects can include nausea, diarrhea, constipation, and vomiting. More serious side effects can occur, but they are less common. Always consult your healthcare provider for any potential side effects.

Semaglutide and Tirzepatide is usually administered by injection under the skin on a weekly basis.

Channelside does not accept insurance at this time. You may check with your primary care provider to see if you qualify for insurance coverage for Semaglutide or Tirzepatide; it will depend on your individual policy. It’s also best to check with your insurance provider to determine whether this medication is covered at all.

Semaglutide is Glucagon-Like Peptide-1 ( GLP-1 )
Tirzepatide is a combination of GLP-1 and Gastric Inhibitory Polypeptide (GIP) hormones.

GLP-1 and GIP are hormones produced naturally in the gut in response to eating. They play a role in regulating blood sugar levels and appetite. GLP-1 medications mimic the effects of the GLP-1 hormone, while GIP medications mimic the effects of the GIP hormone.

GLP-1 medications, such as semaglutide and tirzepatide, are primarily used to treat type 2 diabetes and obesity. They work by:

• Stimulating insulin production, which helps lower blood sugar levels.
• Slowing gastric emptying, which can help you feel fuller for longer and eat less.
• Reducing appetite.

GIP medications, such as tirzepatide, are a newer class of medications that are also being used to treat type 2 diabetes and obesity. They work by:

• Stimulating insulin production.
• Slowing gastric emptying.
• Increasing insulin sensitivity, which helps your body use insulin more effectively.

Both GLP-1 and GIP medications have been shown to be effective in helping people lose weight and improve blood sugar control.

However, they can also cause side effects, such as nausea, vomiting, and diarrhea. It is important to talk to your doctor to see if a GLP-1 or GIP medication is right for you.

GLP-1 medications, particularly semaglutide and tirzepatide, have shown significant efficacy in weight loss and blood sugar control. Here are some key statistics:

Weight Loss:

• Semaglutide can lead to an average weight loss of 15% or more.
• Tirzepatide has shown even greater weight loss potential, with some studies reporting average weight loss exceeding 20%.

Blood Sugar Control:

• Both medications significantly reduce HbA1c levels, a marker of blood sugar control.
• They can help improve insulin sensitivity and reduce the need for other diabetes medications.

Additional Benefits:

• Reduced risk of cardiovascular events
  Improved blood pressure
• Reduced risk of kidney disease

It’s important to note that while GLP-1 medications are highly effective, they are not without side effects, which can include nausea, vomiting, and diarrhea. These side effects are usually mild and tend to subside over time.

It’s crucial to consult with a healthcare provider to determine if GLP-1 medication is right for you and to discuss potential risks and benefits.

The side effects of GLP-1 and GIP medications are often temporary and mild. They tend to occur at the beginning of treatment, especially when the dosage is being increased. Most people experience a significant reduction in these side effects after a few days or weeks of consistent use.

COMMON:

• Injection site reaction
• Headache
• Nausea
• Diarrhea
• Constipation
• Vomiting
• Abdominal pain

LESS COMMON:

• Gallstones

On average, people taking semaglutide have lost around 15% of their body weight.

On average, people taking tirzepatide have lost around 20% of their body weight.

However, individual results may vary.

Several factors can influence how much weight you might lose on semaglutide or tirzepatide, including:

• Starting weight: The higher your starting weight, the more weight you may be able to lose.
• Adherence to the medication: Taking the medication as prescribed and following your doctor’s recommendations are crucial for optimal results.
• Lifestyle changes: Making healthy changes to your diet and exercise habits can further enhance weight loss and improve overall health.

It’s important to remember that semaglutide and tirzepatide are prescription medications, and their use should be discussed with a healthcare provider. They can assess your individual needs and determine if semaglutide or tirzepatide is right for you.